Assessing chemotherapy-induced peripheral neuropathy with patient reported outcome measures: a systematic review of measurement properties and considerations for future use
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Assessing chemotherapy-induced peripheral neuropathy with patient reported outcome measures: a systematic review of measurement properties and considerations for future use
Authors
Keywords
-
Journal
QUALITY OF LIFE RESEARCH
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-05-21
DOI
10.1007/s11136-022-03154-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical assessment of chemotherapy-induced peripheral neuropathy: a discrete choice experiment of patient preferences
- (2021) Alice Yu et al. SUPPORTIVE CARE IN CANCER
- Chemotherapy-Induced Peripheral Neurotoxicity in Cancer Survivors: Predictors of Long-Term Patient Outcomes
- (2021) Eva Battaglini et al. Journal of the National Comprehensive Cancer Network
- Prospective Evaluation of Health Care Provider and Patient Assessments in Chemotherapy-Induced Peripheral Neurotoxicity
- (2021) Paola Alberti et al. NEUROLOGY
- Neuropathy experienced by colorectal cancer patients receiving oxaliplatin: A qualitative study to validate the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity scale
- (2020) Karen Kaiser et al. World Journal of Gastrointestinal Oncology
- The Physical Consequences of Chemotherapy-Induced Peripheral Neuropathy
- (2020) Cindy S. Tofthagen et al. Current Oncology Reports
- Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer
- (2020) Masaaki Miyo et al. BMC CANCER
- Psychometric testing of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group—Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy
- (2020) Hui Lin Cheng et al. Health and Quality of Life Outcomes
- Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
- (2020) Charles L. Loprinzi et al. JOURNAL OF CLINICAL ONCOLOGY
- Evaluating the credibility of anchor based estimates of minimal important differences for patient reported outcomes: instrument development and reliability study
- (2020) Tahira Devji et al. BMJ-British Medical Journal
- Can Methods Developed for Interpreting Group-level Patient-reported Outcome Data be Applied to Individual Patient Management?
- (2019) Madeleine T. King et al. MEDICAL CARE
- Minimal clinically important difference of the EORTC QLQ-CIPN20 for worsening peripheral neuropathy in patients receiving neurotoxic chemotherapy
- (2019) Fiona Yeo et al. SUPPORTIVE CARE IN CANCER
- Optimising clinical screening for chemotherapy-induced peripheral neuropathy
- (2019) J.Matt McCrary et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Development and validation of the comprehensive assessment scale for chemotherapy–induced peripheral neuropathy in survivors of cancer
- (2019) K. Kanda et al. BMC CANCER
- Concerns regarding use of patient-reported outcomes in biomarker studies of chemotherapy-induced peripheral neuropathy
- (2019) Daniel L. Hertz PHARMACOGENOMICS JOURNAL
- Overview and critical revision of clinical assessment tools in chemotherapy‐induced peripheral neurotoxicity
- (2019) Susanna B. Park et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Psychometric evaluation of the Arabic Version the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for Chemotherapy-Induced Peripheral Neuropathy Questionnaire (EORTC QLQ-CIPN20)
- (2019) Loai Abu Sharour Applied Neuropsychology-Adult
- Longitudinal validation and comparison of the Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life-Chemotherapy-Induced Peripheral Neuropathy Questionnaire (EORTC QLQ-CIPN20) and the Functional Assessment of Ca
- (2018) Hui Lin Cheng et al. Asia-Pacific Journal of Clinical Oncology
- Psychometric Testing of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire–Chemotherapy-Induced Peripheral Neuropathy 20-Item Scale Using Pooled Chemotherapy-Induced Peripheral Neuropathy Outcome Measures Standardization and Alliance for Clinical Trials in Oncology A151408 Study Data
- (2018) Ellen M. Lavoie Smith et al. CANCER NURSING
- Paclitaxel Plasma Concentration after the First Infusion Predicts Treatment-Limiting Peripheral Neuropathy
- (2018) Daniel L. Hertz et al. CLINICAL CANCER RESEARCH
- COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study
- (2018) C. B. Terwee et al. QUALITY OF LIFE RESEARCH
- COSMIN guideline for systematic reviews of patient-reported outcome measures
- (2018) C. A. C. Prinsen et al. QUALITY OF LIFE RESEARCH
- In Search of a Gold Standard Patient-Reported Outcome Measure for Use in Chemotherapy- Induced Peripheral Neuropathy Clinical Trials
- (2018) Ellen M. Lavoie Smith et al. Cancer Control
- Development and Validation of Ovarian Symptom Index-18 and Neurotoxicity-4 for Korean Patients with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- (2018) Maria Lee et al. Cancer Research and Treatment
- Concept domain validation and item generation for the Treatment-Induced Neuropathy Assessment Scale (TNAS)
- (2018) Loretta A. Williams et al. SUPPORTIVE CARE IN CANCER
- Rasch model-based testing of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire–Chemotherapy-Induced Peripheral Neuropathy (QLQ-CIPN20) using Alliance for Clinical Trials in Oncology (Alliance) A151408 study data
- (2018) Ellen M. Lavoie Smith et al. SUPPORTIVE CARE IN CANCER
- The psychometric properties of the Turkish version of the Chemotherapy-Induced Peripheral Neuropathy Assessment Tool (CIPNAT)
- (2017) Sevinç Kutlutürkan et al. European Journal of Oncology Nursing
- Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20)
- (2017) Jacobien M. Kieffer et al. QUALITY OF LIFE RESEARCH
- COSMIN Risk of Bias checklist for systematic reviews of Patient-Reported Outcome Measures
- (2017) L. B. Mokkink et al. QUALITY OF LIFE RESEARCH
- Electronic versus paper-pencil methods for assessing chemotherapy-induced peripheral neuropathy
- (2017) Robert Knoerl et al. SUPPORTIVE CARE IN CANCER
- Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey
- (2017) J . Matt McCrary et al. SUPPORTIVE CARE IN CANCER
- Validity of the Chemotherapy-induced Peripheral Neuropathy Self-Check Sheet
- (2015) Yumiko Miyoshi et al. INTERNAL MEDICINE
- Effect of duloxetine in Japanese patients with chemotherapy-induced peripheral neuropathy: a pilot randomized trial
- (2015) Yasuo Hirayama et al. International Journal of Clinical Oncology
- Measuring Therapy-Induced Peripheral Neuropathy: Preliminary Development and Validation of the Treatment-Induced Neuropathy Assessment Scale
- (2015) Tito R. Mendoza et al. JOURNAL OF PAIN
- Reliability testing of oxaliplatin-associated neurotoxicity questionnaire (OANQ), a pilot study
- (2015) E. Gustafsson et al. SUPPORTIVE CARE IN CANCER
- Chemotherapy-induced neuropathy in multiple myeloma: influence on quality of life and development of a questionnaire to compose common toxicity criteria grading for use in daily clinical practice
- (2015) A. J. M. Beijers et al. SUPPORTIVE CARE IN CANCER
- Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
- (2015) Amylou C. Dueck et al. JAMA Oncology
- Reliability and Validity of the Korean Version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire to Assess Chemotherapy-induced Peripheral Neuropathy
- (2015) Hye Young Kim et al. Journal of Korean Academy of Nursing
- Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
- (2014) E. Basch et al. JNCI-Journal of the National Cancer Institute
- Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin
- (2013) P. Alberti et al. ANNALS OF ONCOLOGY
- Chemotherapy-induced peripheral neurotoxicity: A critical analysis
- (2013) Susanna B. Park et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS)
- (2013) D. Binda et al. EUROPEAN JOURNAL OF CANCER
- Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium and Magnesium to Prevent Oxaliplatin-Induced Sensory Neurotoxicity (N08CB/Alliance)
- (2013) Charles L. Loprinzi et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire
- (2013) Ellen M. Lavoie Smith et al. QUALITY OF LIFE RESEARCH
- ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research
- (2013) Bryce B. Reeve et al. QUALITY OF LIFE RESEARCH
- The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings
- (2012) G. Cavaletti et al. ANNALS OF ONCOLOGY
- Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy
- (2012) Brandi N. Reeves et al. CANCER
- The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA
- (2012) Sherry L. Wolf et al. SUPPORTIVE CARE IN CANCER
- Development and Psychometric Evaluation of the Chemotherapy-Induced Peripheral Neuropathy Assessment Tool
- (2011) Cindy S. Tofthagen et al. CANCER NURSING
- Precise evaluation of chemotherapy-induced peripheral neuropathy using the visual analogue scale: a quantitative and comparative analysis of neuropathy occurring with paclitaxel–carboplatin and docetaxel–carboplatin therapy
- (2011) Shuji Takemoto et al. International Journal of Clinical Oncology
- Natural History of Paclitaxel-Associated Acute Pain Syndrome: Prospective Cohort Study NCCTG N08C1
- (2011) Charles L. Loprinzi et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessing the impact of chemotherapy-induced peripheral neurotoxicity on the quality of life of cancer patients
- (2011) C. M. L. Driessen et al. SUPPORTIVE CARE IN CANCER
- Measures of chemotherapy-induced peripheral neuropathy: a systematic review of psychometric properties
- (2010) Kathleen A. Griffith et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA
- (2010) Debra L. Barton et al. SUPPORTIVE CARE IN CANCER
- Development of a methodological PubMed search filter for finding studies on measurement properties of measurement instruments
- (2009) Caroline B. Terwee et al. QUALITY OF LIFE RESEARCH
- Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02
- (2009) Kojiro Shimozuma et al. SUPPORTIVE CARE IN CANCER
- Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes
- (2007) Dennis Revicki et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now